Procaps Group (NASDAQ:PROC) Stock Price Down 40.3% – Time to Sell?

Procaps Group S.A. (NASDAQ:PROC) shares were down 40.3% during mid-day trading on Friday . The company traded as low as $0.77 and last traded at $0.95. Approximately 658,169 shares were traded during mid-day trading, an increase of 1,594% from the average daily volume of 38,864 shares. The stock had previously closed at $1.59.

Procaps Group Stock Down 40.3 %

The stock has a fifty day moving average price of $1.24 and a 200-day moving average price of $1.68.

Institutional Investors Weigh In On Procaps Group

A hedge fund recently bought a new stake in Procaps Group stock. Itau Unibanco Holding S.A. purchased a new position in Procaps Group S.A. (NASDAQ:PROC) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 177,974 shares of the company’s stock, valued at approximately $416,000. Itau Unibanco Holding S.A. owned approximately 0.16% of Procaps Group at the end of the most recent reporting period.

Procaps Group Company Profile

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.